Drug Profile
AS 6
Latest Information Update: 09 Jul 1996
Price :
$50
*
At a glance
- Originator Institute of Medical Science St. Marianna University
- Developer Institute of Medical Science St. Marianna University; Pharmacia Corporation
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 09 Jul 1996 Discontinued-Preclinical for Diabetes mellitus in Japan (Unknown route)
- 31 Mar 1995 New profile
- 31 Mar 1995 Preclinical development for Diabetes mellitus in Japan (Unknown route)